Molecular Diagnostics
Early-Pregnancy Urine Test Could Predict Preeclampsia
Researchers have discovered biomarkers in the blood and urine of women with preeclampsia that could lead to a low-cost test to predict the condition months before a pregnant woman shows symptoms. Predictive testing would enable better pregnancy monitoring and the development of more effective treatments. More...12 Dec 2022
Portable qPCR Platform Enables Faster, Better, Low-Cost Near-Patient Molecular Diagnosis
The point-of-care molecular diagnostics space seems to have gotten more crowded during COVID. Now, a portable molecular diagnostics platform with 16-well capabilities differentiates itself from most competitors who use single cartridge or single test formats. More...12 Dec 2022
Long COVID Etiologies Found in Acute Infection Blood Samples
Long COVID or long-haul COVID (also known as post-acute sequelae of COVID-19 [PASC], or chronic COVID syndrome [CCS]) is a condition characterized by long-term health problems persisting or appearing after the typical recovery period of COVID-19. More...12 Dec 2022
POCT Immunoassay Reader Provides Quantitative Analysis of Test Kits for More Accurate Diagnosis
A small, light-weight quantitative immunoassay reader that provides a quantitative analysis of any kind of rapid test kits or strips, and can be connected to a PC or laptop, smartphone or tablet, offers a reliable, convenient and affordable POCT solution for accurate disease diagnosis. More...12 Dec 2022
World’s First Rapid Saliva-Based Pregnancy Test Eliminates Need for Blood and Urine Samples
Salistick from Salignostics (Jerusalem, Israel) is the first rapid saliva-based pregnancy test for early and highly accurate pregnancy detection that does not require urine. The kit is based on the company’s revolutionary technology which detects the pregnancy hormone β-hCG in saliva from the first day of the missed period. More...09 Dec 2022
Cepheid's Multi-Target Test Design Enables Detection of Influenza Variants
Cepheid’s (Sunnyvale, CA, USA) respiratory test design enables detection of the currently circulating mutant strains of influenza, and with similar symptoms across various illnesses such as the flu, respiratory syncytial virus (RSV) disease, and COVID-19, when accurate and fast diagnosis is critical to patient care. More...09 Dec 2022
Portable UTI Molecular Diagnostic Platform Provides Accurate Test Results in 40 Minutes
The absence of fast diagnostic testing for Urinary Tract Infections (UTIs) means clinicians make treatment decisions based on vague clinical symptoms or inaccurate urine dipstick tests. Now, a rapid and affordable point-of-care molecular diagnostics platform developed specifically to detect bacterial and viral infections aims to change that. More...09 Dec 2022
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
 assay.jpg)
New
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
Silver Member
PCR Plates
Diamond Shell PCR Plates
Capillary Blood Collection Tube
IMPROMINI M3
In Other News
New Blood Test Detects ‘Toxic’ Protein Years Before Alzheimer’s Symptoms Emerge
Biomarkers Predict Lyme Disease Post-Treatment Prognosis
Low Cost, Highly Sensitive Blood Test for Cancer Makes Regular Monitoring Affordable
New All-In-One Molecular Diagnostic System Realizes True Sample In -Result Out Detection Process
Method Enables Targeted Profiling of Human Extrachromosomal DNA
ctDNA-Based MRD Test to Detect As Few As One Mutant Molecule in a Million DNA Molecules
Study Identifies Optimal Blood Tests for Detection and Treatment of Early Stage Alzheimer’s
Blood Test for Protein Biomarker Could Detect Pancreatic Cancer at Very Early Stage
Blood Tests Could Predict Survival Odds for Patients with Metastatic Cancer
New Serological Test Could Search for Viral Triggers of Diseases
Blood-Based NIPS Test Improves Access to Genetic Testing
Two Tau Variants Distinguish Corticobasal Degeneration from Other Tauopathies
First-Ever Blood Test Could Detect Deadly Heart Inflammation Within Hours
Urine-Based, Non-Invasive Molecular Test Accurately Detects Bladder Cancer
Altered Ratios of p53 Isoforms Predict Response of Breast Tumors to Chemotherapy
Benchtop Immunoanalyzer Delivers Lab Quality Results for Cardiology, Intensive Care and Emergency Wards at POC
Blood Test Could Screen for Changes in Proteins Prior to Breast Cancer Diagnosis
Tumor Biopsies Analysis Performed on Newly-diagnosed B-cell Neoplasms
Acute COVID-19 Infections Are Characterized by Elevated Blood Levels of IL-26
New Tool Assesses Cost of ctDNA Testing
Multiplex Vaginal Panel Identifies Three Distinct Conditions in One Hour
Novel Assay Enables Simultaneous Detection of SMA and SCID in Newborns
Simple Blood Test Could More Than Double Liver Cancer Detection Rate in High-Risk Population
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
